Cargando…
Novel nanocrystal formulation of megestrol acetate has improved bioavailability compared with the conventional micronized formulation in the fasting state
BACKGROUND: Megestrol acetate is an effective treatment for improving appetite and increasing body weight in patients with cancer-associated anorexia. However, Megace(®) oral suspension (OS), a micronized formulation of megestrol acetate, has low bioavailability in the fasting state. To overcome thi...
Autores principales: | Jang, Kyungho, Yoon, Seonghae, Kim, Sung-Eun, Cho, Joo-Youn, Yoon, Seo Hyun, Lim, Kyoung Soo, Yu, Kyung-Sang, Jang, In-Jin, Lee, Howard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4077389/ https://www.ncbi.nlm.nih.gov/pubmed/25028536 http://dx.doi.org/10.2147/DDDT.S62176 |
Ejemplares similares
-
Food effect on the bioavailability of two distinct formulations of megestrol acetate oral suspension
por: Deschamps, Benoit, et al.
Publicado: (2009) -
Precipitation Reaction of SDS and Potassium Salts in Flocculation of a Micronized Megestrol Acetate Suspension
por: Hejazi, Seyed Mahdi, et al.
Publicado: (2013) -
Efficacy of a micronized, nanocrystal fenofibrate formulation in treatment of hyperlipidemia in dogs
por: Munro, Matthew J. L., et al.
Publicado: (2021) -
Megestrol acetate in cachexia and anorexia
por: Yeh, Shing-shing, et al.
Publicado: (2006) -
Comparative steady-state pharmacokinetic study of an extended-release formulation of itopride and its immediate-release reference formulation in healthy volunteers
por: Yoon, Seonghae, et al.
Publicado: (2014)